Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477711
Status:
COMPLETED
Last Update Posted:
2015-05-19
First Post:
2007-05-22
Brief Title:
A Study of CetuximabErbitux With Cisplatin and CapecitabineXelodaas 1st Line Treatment in the Advanced Gastric Cancer
Sponsor:
Peking University
Organization:
Peking University